Cargando…
Optimizing antimicrobial prescribing: Are clinicians following national trends in methicillin-resistant staphylococcus aureus (MRSA) infections rather than local data when treating MRSA wound infections
BACKGROUND: Clinicians often prescribe antimicrobials for outpatient wound infections before culture results are known. Local or national MRSA rates may be considered when prescribing antimicrobials. If clinicians prescribe in response to national rather than local MRSA trends, prescribing may be im...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853220/ https://www.ncbi.nlm.nih.gov/pubmed/24128420 http://dx.doi.org/10.1186/2047-2994-2-28 |
_version_ | 1782478800422961152 |
---|---|
author | Schweizer, Marin L Perencevich, Eli N Eber, Michael R Cai, Xueya Shardell, Michelle D Braykov, Nikolay Laxminarayan, Ramanan |
author_facet | Schweizer, Marin L Perencevich, Eli N Eber, Michael R Cai, Xueya Shardell, Michelle D Braykov, Nikolay Laxminarayan, Ramanan |
author_sort | Schweizer, Marin L |
collection | PubMed |
description | BACKGROUND: Clinicians often prescribe antimicrobials for outpatient wound infections before culture results are known. Local or national MRSA rates may be considered when prescribing antimicrobials. If clinicians prescribe in response to national rather than local MRSA trends, prescribing may be improved by making local data accessible. We aimed to assess the correlation between outpatient trends in antimicrobial prescribing and the prevalence of MRSA wound infections across local and national levels. METHODS: Monthly MRSA positive wound culture counts were obtained from The Surveillance Network, a database of antimicrobial susceptibilities from clinical laboratories across 278 zip codes from 1999–2007. Monthly outpatient retail sales of linezolid, clindamycin, trimethoprim-sulfamethoxazole and cephalexin from 1999–2007 were obtained from the IMS Health Xponent(TM) database. Rates were created using census populations. The proportion of variance in prescribing that could be explained by MRSA rates was assessed by the coefficient of determination (R(2)), using population weighted linear regression. RESULTS: 107,215 MRSA positive wound cultures and 106,641,604 antimicrobial prescriptions were assessed. The R(2) was low when zip code-level antimicrobial prescription rates were compared to MRSA rates at all levels. State-level prescriptions of clindamycin and linezolid were not correlated with state MRSA rates. The variance in state-level prescribing of clindamycin and linezolid was correlated with national MRSA rates (clindamycin R(2) = 0.17, linezolid R(2) = 0.22). CONCLUSIONS: Clinicians may rely on national, not local MRSA data when prescribing clindamycin and linezolid for wound infections. Providing local resistance data to prescribing clinicians may improve antimicrobial prescribing and would be a possible target for future interventions. |
format | Online Article Text |
id | pubmed-3853220 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-38532202013-12-07 Optimizing antimicrobial prescribing: Are clinicians following national trends in methicillin-resistant staphylococcus aureus (MRSA) infections rather than local data when treating MRSA wound infections Schweizer, Marin L Perencevich, Eli N Eber, Michael R Cai, Xueya Shardell, Michelle D Braykov, Nikolay Laxminarayan, Ramanan Antimicrob Resist Infect Control Research BACKGROUND: Clinicians often prescribe antimicrobials for outpatient wound infections before culture results are known. Local or national MRSA rates may be considered when prescribing antimicrobials. If clinicians prescribe in response to national rather than local MRSA trends, prescribing may be improved by making local data accessible. We aimed to assess the correlation between outpatient trends in antimicrobial prescribing and the prevalence of MRSA wound infections across local and national levels. METHODS: Monthly MRSA positive wound culture counts were obtained from The Surveillance Network, a database of antimicrobial susceptibilities from clinical laboratories across 278 zip codes from 1999–2007. Monthly outpatient retail sales of linezolid, clindamycin, trimethoprim-sulfamethoxazole and cephalexin from 1999–2007 were obtained from the IMS Health Xponent(TM) database. Rates were created using census populations. The proportion of variance in prescribing that could be explained by MRSA rates was assessed by the coefficient of determination (R(2)), using population weighted linear regression. RESULTS: 107,215 MRSA positive wound cultures and 106,641,604 antimicrobial prescriptions were assessed. The R(2) was low when zip code-level antimicrobial prescription rates were compared to MRSA rates at all levels. State-level prescriptions of clindamycin and linezolid were not correlated with state MRSA rates. The variance in state-level prescribing of clindamycin and linezolid was correlated with national MRSA rates (clindamycin R(2) = 0.17, linezolid R(2) = 0.22). CONCLUSIONS: Clinicians may rely on national, not local MRSA data when prescribing clindamycin and linezolid for wound infections. Providing local resistance data to prescribing clinicians may improve antimicrobial prescribing and would be a possible target for future interventions. BioMed Central 2013-10-15 /pmc/articles/PMC3853220/ /pubmed/24128420 http://dx.doi.org/10.1186/2047-2994-2-28 Text en Copyright © 2013 Schweizer et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Schweizer, Marin L Perencevich, Eli N Eber, Michael R Cai, Xueya Shardell, Michelle D Braykov, Nikolay Laxminarayan, Ramanan Optimizing antimicrobial prescribing: Are clinicians following national trends in methicillin-resistant staphylococcus aureus (MRSA) infections rather than local data when treating MRSA wound infections |
title | Optimizing antimicrobial prescribing: Are clinicians following national trends in methicillin-resistant staphylococcus aureus (MRSA) infections rather than local data when treating MRSA wound infections |
title_full | Optimizing antimicrobial prescribing: Are clinicians following national trends in methicillin-resistant staphylococcus aureus (MRSA) infections rather than local data when treating MRSA wound infections |
title_fullStr | Optimizing antimicrobial prescribing: Are clinicians following national trends in methicillin-resistant staphylococcus aureus (MRSA) infections rather than local data when treating MRSA wound infections |
title_full_unstemmed | Optimizing antimicrobial prescribing: Are clinicians following national trends in methicillin-resistant staphylococcus aureus (MRSA) infections rather than local data when treating MRSA wound infections |
title_short | Optimizing antimicrobial prescribing: Are clinicians following national trends in methicillin-resistant staphylococcus aureus (MRSA) infections rather than local data when treating MRSA wound infections |
title_sort | optimizing antimicrobial prescribing: are clinicians following national trends in methicillin-resistant staphylococcus aureus (mrsa) infections rather than local data when treating mrsa wound infections |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853220/ https://www.ncbi.nlm.nih.gov/pubmed/24128420 http://dx.doi.org/10.1186/2047-2994-2-28 |
work_keys_str_mv | AT schweizermarinl optimizingantimicrobialprescribingarecliniciansfollowingnationaltrendsinmethicillinresistantstaphylococcusaureusmrsainfectionsratherthanlocaldatawhentreatingmrsawoundinfections AT perencevichelin optimizingantimicrobialprescribingarecliniciansfollowingnationaltrendsinmethicillinresistantstaphylococcusaureusmrsainfectionsratherthanlocaldatawhentreatingmrsawoundinfections AT ebermichaelr optimizingantimicrobialprescribingarecliniciansfollowingnationaltrendsinmethicillinresistantstaphylococcusaureusmrsainfectionsratherthanlocaldatawhentreatingmrsawoundinfections AT caixueya optimizingantimicrobialprescribingarecliniciansfollowingnationaltrendsinmethicillinresistantstaphylococcusaureusmrsainfectionsratherthanlocaldatawhentreatingmrsawoundinfections AT shardellmichelled optimizingantimicrobialprescribingarecliniciansfollowingnationaltrendsinmethicillinresistantstaphylococcusaureusmrsainfectionsratherthanlocaldatawhentreatingmrsawoundinfections AT braykovnikolay optimizingantimicrobialprescribingarecliniciansfollowingnationaltrendsinmethicillinresistantstaphylococcusaureusmrsainfectionsratherthanlocaldatawhentreatingmrsawoundinfections AT laxminarayanramanan optimizingantimicrobialprescribingarecliniciansfollowingnationaltrendsinmethicillinresistantstaphylococcusaureusmrsainfectionsratherthanlocaldatawhentreatingmrsawoundinfections |